Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pul… Read more
Market Cap & Net Worth: Neuronetics Inc (STIM)
Neuronetics Inc (NASDAQ:STIM) has a market capitalization of $83.90 Million ($83.90 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21494 globally and #7701 in its home market, demonstrating a -7.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neuronetics Inc's stock price $1.23 by its total outstanding shares 68485922 (68.49 Million).
Neuronetics Inc Market Cap History: 2018 to 2026
Neuronetics Inc's market capitalization history from 2018 to 2026. Data shows change from $1.33 Billion to $83.90 Million (-33.25% CAGR).
Index Memberships
Neuronetics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #584 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1923 of 3165 |
Weight: Neuronetics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neuronetics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neuronetics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.47x
Neuronetics Inc's market cap is 1.47 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.33 Billion | $52.78 Million | -$24.10 Million | 25.11x | N/A |
| 2019 | $307.50 Million | $62.66 Million | -$29.04 Million | 4.91x | N/A |
| 2020 | $760.88 Million | $49.24 Million | -$27.45 Million | 15.45x | N/A |
| 2021 | $305.45 Million | $55.31 Million | -$31.19 Million | 5.52x | N/A |
| 2022 | $470.50 Million | $65.21 Million | -$37.16 Million | 7.22x | N/A |
| 2023 | $198.61 Million | $71.35 Million | -$30.19 Million | 2.78x | N/A |
| 2024 | $110.26 Million | $74.89 Million | -$43.71 Million | 1.47x | N/A |
Competitor Companies of STIM by Market Capitalization
Companies near Neuronetics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Neuronetics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Neuronetics Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Neuronetics Inc's market cap moved from $1.33 Billion to $ 83.90 Million, with a yearly change of -33.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $83.90 Million | -11.23% |
| 2025 | $94.51 Million | -14.29% |
| 2024 | $110.26 Million | -44.48% |
| 2023 | $198.61 Million | -57.79% |
| 2022 | $470.50 Million | +54.04% |
| 2021 | $305.45 Million | -59.86% |
| 2020 | $760.88 Million | +147.44% |
| 2019 | $307.50 Million | -76.80% |
| 2018 | $1.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Neuronetics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $83.90 Million USD |
| MoneyControl | $83.90 Million USD |
| MarketWatch | $83.90 Million USD |
| marketcap.company | $83.90 Million USD |
| Reuters | $83.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.